Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age
Catherine A. Byrnes, Suzanna Vidmar, Keith Grimwood(Royal Children's Hospital), Marj Moodie(Deakin University), Claire Wainwright(Royal Children's Hospital), Margaret Rosenfeld(Seattle Children's Hospital), Harm A.W.M. Tiddens(Erasmus MC), David Armstrong, Peter Cooper(University of Reading), Joyce Cheney, John B. Carlin(The University of Melbourne), Colin Robertson(Murdoch Children's Research Institute)
Cited by 96
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Multiple Imputation for Missing Data: Fully Conditional Specification Versus Multivariate Normal Imputation
|American Journal of Epidemiology|2010|793
The natural history of self-harm from adolescence to young adulthood: a population-based cohort study
|The Lancet|2011|607